These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 39329757)

  • 1. Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets.
    Cortes Ballen AI; Amosu M; Ravinder S; Chan J; Derin E; Slika H; Tyler B
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.
    Agnihotri S; Zadeh G
    Neuro Oncol; 2016 Feb; 18(2):160-72. PubMed ID: 26180081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond glucose: alternative sources of energy in glioblastoma.
    Caniglia JL; Jalasutram A; Asuthkar S; Sahagun J; Park S; Ravindra A; Tsung AJ; Guda MR; Velpula KK
    Theranostics; 2021; 11(5):2048-2057. PubMed ID: 33500708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma cells require one-carbon metabolism to survive glutamine starvation.
    Tanaka K; Sasayama T; Nagashima H; Irino Y; Takahashi M; Izumi Y; Uno T; Satoh N; Kitta A; Kyotani K; Fujita Y; Hashiguchi M; Nakai T; Kohta M; Uozumi Y; Shinohara M; Hosoda K; Bamba T; Kohmura E
    Acta Neuropathol Commun; 2021 Jan; 9(1):16. PubMed ID: 33468252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
    Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting metabolic remodeling in glioblastoma multiforme.
    Wolf A; Agnihotri S; Guha A
    Oncotarget; 2010 Nov; 1(7):552-62. PubMed ID: 21317451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
    Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
    Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
    [No Abstract]   [Full Text] [Related]  

  • 8. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
    DeBerardinis RJ; Mancuso A; Daikhin E; Nissim I; Yudkoff M; Wehrli S; Thompson CB
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19345-50. PubMed ID: 18032601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment.
    Lee H; Kim D; Youn B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Contrasts: Fatty Acid Oxidation and Ketone Bodies in Healthy Brains vs. Glioblastoma Multiforme.
    Tamas C; Tamas F; Kovecsi A; Cehan A; Balasa A
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic therapy: a new paradigm for managing malignant brain cancer.
    Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
    Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamine Metabolism Heterogeneity in Glioblastoma Unveils an Innovative Combination Therapy Strategy.
    Fu H; Wu S; Shen H; Luo K; Huang Z; Lu N; Li Y; Lan Q; Xian Y
    J Mol Neurosci; 2024 May; 74(2):52. PubMed ID: 38724832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
    Tanaka K; Sasayama T; Irino Y; Takata K; Nagashima H; Satoh N; Kyotani K; Mizowaki T; Imahori T; Ejima Y; Masui K; Gini B; Yang H; Hosoda K; Sasaki R; Mischel PS; Kohmura E
    J Clin Invest; 2015 Apr; 125(4):1591-602. PubMed ID: 25798620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Multifaceted Metabolism of Glioblastoma.
    Quinones A; Le A
    Adv Exp Med Biol; 2018; 1063():59-72. PubMed ID: 29946775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Reprogramming of Glioblastoma Cells during HCMV Infection Induces Secretome-Mediated Paracrine Effects in the Microenvironment.
    Harrison MAA; Hochreiner EM; Benjamin BP; Lawler SE; Zwezdaryk KJ
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Drivers of Invasion in Glioblastoma.
    Garcia JH; Jain S; Aghi MK
    Front Cell Dev Biol; 2021; 9():683276. PubMed ID: 34277624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumors.
    Shan M; Dai D; Vudem A; Varner JD; Stroock AD
    PLoS Comput Biol; 2018 Dec; 14(12):e1006584. PubMed ID: 30532226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PT109, a novel multi-kinase inhibitor suppresses glioblastoma multiforme through cell reprogramming: Involvement of PTBP1/PKM1/2 pathway.
    Yang Y; Tu Y; Lu J; Chen Q; Zhu Z; Peng W; Zhu W; Wen S; Zhang J; Yin W; Pi R
    Eur J Pharmacol; 2022 Apr; 920():174837. PubMed ID: 35218719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.
    Abbadi S; Rodarte JJ; Abutaleb A; Lavell E; Smith CL; Ruff W; Schiller J; Olivi A; Levchenko A; Guerrero-Cazares H; Quinones-Hinojosa A
    Mol Cancer Res; 2014 Nov; 12(11):1547-59. PubMed ID: 25001192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors.
    Yuan J; Zhang F; Hallahan D; Zhang Z; He L; Wu LG; You M; Yang Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):181. PubMed ID: 30071868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.